* Modified from reference [2].
NHSN: National Healthcare Safety Network;
SSI: surgical site infection;
OX/METH: oxacillin/methicillin;
ESC4: extended spectrum(ES) cephalosporins (cefepime, cefotaxime, ceftazidime, ceftriaxone);
FQ3: fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin);
MDR1: multidrug resistance 1 gene (pathogen must test as “I” [intermediate] or “R” [resistant] to at least one drug in 3 of the 5 following classes: ESC4, FQ3, aminoglycosides, carbapenems*, and piperacillin [PIP] or piperacillin/tazobactam [PIP/TAZ]);
NA: not available;
VAN: vancomycin;
AMINOS: aminoglycosides (amikacin, gentamicin, tobramycin);
ESC2: ES cephalosporins (cefepime, ceftazidime);
MDR2: multidrug resistance 2 gene (pathogen must test as I or R to at least 1 drug in 3 of the 5 following classes: ESC2, FQ2, AMINOS, carbapenems, and PIP or PIP/TAZ.
* Carbapenems are imipenem and meropenem.
국내 2009년도 : national SSI surveillance system report
operation | The SSI rate per 100 operations |
craniotomy | 3.68% (22/1169) |
ventricular shunt operation | 5.96% (14/235) |
gastric operations | 4.25% (75/1763) |
colon surgery | 3.37% (22/653) |
rectal surgery | 5.83% (27/463) |
hip joint replacement | 1.93% (23/1190) |
knee joint replacement | 2.63% (30/1139) |
국내 2008-2012년도
operation | The SSI rate per 100 operations |
gastrectomy | 3.12% (522/16 918) |
total hip arthroplasty | 2.05% (157/7656) |
total knee arthroplasty | 1.90% (152/7648) |
reference :
1) World Health Organization. (2018). Global guidelines for the prevention of surgical site infection, 2nd ed.. World Health Organization. https://apps.who.int/iris/handle/10665/277399. License: CC BY-NC-SA 3.0 IGO
2) Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, et al. Antimicrobial resistant pathogens associated with healthcare associated infections: summary of data reported to the National Healthcare Safety
Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013;34(1):1-14.
'🤹♂️ 카테고리별 약물 > 감염' 카테고리의 다른 글
Daptomycin, 답토신 주 350 MG, MRSA bacteremia, SSTI (0) | 2021.02.15 |
---|---|
항결핵제, linezolid, 다제내성 결핵에서의 linezolid, 보험 심사 기준 (0) | 2021.02.09 |
2020년 결핵 진료 지침 4판, 2020년 vs 2017년, 항결핵제 분류 (0) | 2021.01.17 |
패혈증 환자, 스테로이드 요법, hydrocortisone hydrocortisone intermittent vs. continuous infusion, tapering (0) | 2021.01.10 |
패혈증 비타민/스테로이드 요법, Vitamin C(ascorbic acid), Hydrocortisone, Thiamine (0) | 2021.01.09 |
댓글